| Lipoprotein (a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp (a) Registry A Shiyovich, AN Berman, SA Besser, DW Biery, R Cardoso, S Divakaran, ... Cardiovascular Diabetology 23 (1), 257, 2024 | | 2024 |
| The Lomitapide Observational Worldwide Evaluation Registry (LOWER)-Nine-year Effectiveness and Safety Data in HoFH J Underberg, C Cannon, D Larrey, L Makris, S O'Brien, D Blom Journal of Clinical Lipidology 18 (4), e545, 2024 | | 2024 |
| Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant‐level pooled analysis from the CANVAS Program and CREDENCE trial M Vaduganathan, CP Cannon, MJ Jardine, HJL Heerspink, C Arnott, ... European Journal of Heart Failure, 2024 | | 2024 |
| Randomized trial of a vascular care team vs education for patients with peripheral artery disease CN Hess, A Daffron, MR Nehler, JT Morrison, CE Buchanan, M Szarek, ... Journal of the American College of Cardiology 83 (25), 2658-2670, 2024 | 2 | 2024 |
| Hypoglycaemia and kidney events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial A Odutayo, F Cosentino, RE Pratley, S Dagogo‐Jack, DK McGuire, ... Diabetes, Obesity and Metabolism, 2024 | | 2024 |
| Randomized Evaluation of a Remote Management Program to Improve Guideline-Directed Medical Therapy: The DRIVE Trial AJ Blood, LS Chang, S Hassan, J Chasse, G Stern, D Gabovitch, D Zelle, ... Circulation 149 (23), 1802-1811, 2024 | | 2024 |
| Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp (a) Registry A Shiyovich, AN Berman, SA Besser, DW Biery, G Kaur, S Divakaran, ... Journal of the American Heart Association 13 (10), e034493, 2024 | 1 | 2024 |
| Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis C Reith, D Preiss, L Blackwell, J Emberson, E Spata, K Davies, H Halls, ... The Lancet Diabetes & Endocrinology 12 (5), 306-319, 2024 | 8 | 2024 |
| The year in cardiovascular medicine 2023: the top 10 papers in diabetes and metabolic disorders F Cosentino, CP Cannon, N Marx European Heart Journal 45 (14), 1205-1208, 2024 | 2 | 2024 |
| CONTEMPORARY ANTI-OBESITY PHARMACOTHERAPY PRESCRIBING PATTERNS IN A LARGE US TERTIARY HEALTHCARE SYSTEM, 2018-2022 J Ostrominski, K Wagholikar, D Zelle, O Unlu, S Kumar, M Tucci, ... Journal of the American College of Cardiology 83 (13_Supplement), 1978-1978, 2024 | | 2024 |
| THE ASSOCIATION OF IMMUNE-MEDIATED INFLAMMATORY DISEASE AND LIPOPROTEIN (A) WITH MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG INDIVIDUALS WITH AND WITHOUT BASELINE … B Weber, AN Berman, SA Besser, D Huck, JM Hainer, A Shiyovich, ... Journal of the American College of Cardiology 83 (13_Supplement), 1681-1681, 2024 | | 2024 |
| Concurrent Evaluation of hsTnI and hsTnT and Their Associations with Cardiovascular Events in 37,886 Patients with Stable Atherosclerotic Cardiovascular Disease RP Bajaj, MP Bonaca, P Jarolim, EL Goodrich, R Blaustein, L Bowman, ... Journal of the American College of Cardiology 83 (13_Supplement), 1254-1254, 2024 | | 2024 |
| LONG-TERM BLOOD PRESSURE TRENDS FOLLOWING A REMOTE HYPERTENSION INTERVENTION S Hassan, A Blood, D Zelle, D Gabovitch, O Unlu, S Kumar, K Wagholikar, ... Journal of the American College of Cardiology 83 (13_Supplement), 2439-2439, 2024 | | 2024 |
| SUCCESS OF A REMOTELY DELIVERED LIPID PROGRAM IN ACHIEVING TARGET LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS O Unlu, A Blood, CP Cannon, C Mailly, S Subramaniam, M Tucci, ... Journal of the American College of Cardiology 83 (13_Supplement), 2445-2445, 2024 | | 2024 |
| REAL-WORLD APPLICATION OF SELECT TRIAL CRITERIA IN A LARGE URBAN AND SUBURBAN HEALTH SYSTEM A Blood, J Ostrominski, O Unlu, D Zelle, K Wagholikar, S Kumar, J Plutzky, ... Journal of the American College of Cardiology 83 (13_Supplement), 1308-1308, 2024 | | 2024 |
| PATIENT ENGAGEMENT WITH HOME BLOOD PRESSURE MONITORING IN A REMOTE HYPERTENSION MANAGEMENT PROGRAM: HOW MANY MEASUREMENTS DO PATIENTS TAKE AT HOME? O Unlu, D Zelle, CP Cannon, S Lee, M McPartlin, S Subramaniam, ... Journal of the American College of Cardiology 83 (13_Supplement), 1873-1873, 2024 | | 2024 |
| Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trial R Aggarwal, DL Bhatt, M Szarek, LA Leiter, CP Cannon, RD Lopes, ... European journal of heart failure 26 (4), 1093-1095, 2024 | | 2024 |
| Methods, rationale, and design for a remote pharmacist and navigator-driven disease management program to improve guideline-directed medical therapy in patients with type 2 … AJ Blood, LS Chang, C Colling, G Stern, D Gabovitch, G Feldman, A Adan, ... Primary Care Diabetes 18 (2), 202-209, 2024 | 1 | 2024 |
| Lipoprotein (a) and major adverse cardiovascular events in patients with or without baseline atherosclerotic cardiovascular disease AN Berman, DW Biery, SA Besser, A Singh, A Shiyovich, BN Weber, ... Journal of the American College of Cardiology 83 (9), 873-886, 2024 | 14 | 2024 |
| How Generalizable Is The Soloist-whf Trial In ‘Real World’Patients With Diabetes Admitted With Heart Failure? Results From A Large Us Integrated Health System ME Canonico, J Hsia, M Szarek, CP Cannon, MP Bonaca Journal of Cardiac Failure 30 (1), 228-228, 2024 | | 2024 |
